Related Experiment Videos
The new treatments of hyperparathyroidism secondary to renal insufficiency
A Fournier1, T Drüeke, P Morinière
1Service de Néphrologie, Centre Hospitalier Régional, Universitaire d'Amiens, France.
Advances in Nephrology From the Necker Hospital
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
The Journal of pharmacology and experimental therapeutics·1992
Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation.
The Journal of pharmacology and experimental therapeutics·1992
Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
The Journal of pharmacology and experimental therapeutics·1992
Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.
Kidney international·1992
Angiotensin-induced inflammation and novel approaches to treatment.
Advances in nephrology from the Necker Hospital·2001
Renal fibrosis and the renin-angiotensin system.
Advances in nephrology from the Necker Hospital·2001
What is the optimal blood pressure target in renal patients?
Advances in nephrology from the Necker Hospital·2001
A mixture of pomegranate peels and propolis extracts reduces inflammation associated with rheumatoid arthritis in vivo.
Frontiers in pharmacology·2026
Ocular Adverse Events Associated with Docetaxel and Paclitaxel: A Pharmacovigilance Disproportionality Analysis.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2026
Hypoparathyroidism: a review of clinical trials and recent approvals.
Expert opinion on pharmacotherapy·2026